Dr. Yupeng Ren joined China Clinical Pharmacology and Pharmacometrics Department of Janssen China R&D in 2019. He took the leader role of pharmacometrics in China and built a dedicated pharmacometrics team in 2020. Dr. Ren is responsible for multiple pharmacometrics analyses for clinical development and submissions of global and local projects in Janssen. Before he joined Janssen, Dr. Ren worked at the Office of Clinical Pharmacology of the U.S. FDA as a research fellow from 2017 to 2019 and did the postdoctoral work at the Clinical Pharmacology Research Center of Peking Union Medical College Hospital. Dr. Yupeng Ren got his doctor’s and master’s degrees, majoring in pharmacometrics, in Peking University in 2015 and 2011, respectively.

任宇鹏博士于2019 年加入杨森中国研发中心临床药理部门，并于2020 年开始担任中国区定量药理学负责人并组建了独立的定量药理学团队。在杨森工作期间，任博士负责了多项国际和国内新药临床开发和申报中的定量药理学分析。加入杨森之前，于2017 年-2019 年在美国⾷品药品监督管理局临床药理办公室作访问学者，于2015 年-2016 年在北京协和医院临床药理研究中心从事科研助理工作。并分别于2015 年和2011 年从北京大学分别获得博士和硕士学位，研究方向均为定量药理学。